Galectin-1 Promotes Gastric Carcinoma Progression and Cisplatin Resistance Through the NRP-1/c-JUN/Wee1 Pathway.

Zhengyang Pan Guoxi Xu Yan Zhang Meiling Wu Jiahui Yu Xujun He Wei Zhang Junfeng Hu

Published in: Journal of gastric cancer (2024)

These findings revealed a potential mechanism by which Gal-1 promotes GC growth and contributes to chemoresistance, offering new therapeutic targets for the treatment of GC.

Keyphrases

gas chromatography
single cell
mass spectrometry
combination therapy
risk assessment
climate change
smoking cessation